Short- and long-term outcomes of acute upper extremity arterial thromboembolism. 2010

Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
Deparment of Cardiovascular Surgery, Nayoro City General Hospital, Hokkaido, Nayoro, Japan.

OBJECTIVE To evaluate the short-/long-term outcomes after acute thromboembolism of the upper extremity. METHODS Twenty-one patients with acute arterial occlusion in the upper extremity were treated from January 1993 to July 2007 at our hospital. Their average age was 73.0, and 14 (66%) were male. The right and left limbs were affected in 15 cases (71%) and 6 cases (29%), respectively. The main associated disease was arrhythmia, in 20 cases (95%), including atrial fibrillation in 17 (81%). The time from onset to operation was 9.7 +/- 9.2 h (range: 2-41 h). All patients underwent thromboembolectomy with a Fogarty catheter. RESULTS The symptoms showed regression in all cases after operation, but one patient died from cerebral infarction the following day. Anticoagulant and antiplatelet therapies are commonly prescribed in cases after thromboembolectomy. The free rates of thromboembolism were 74% and 27%, and cumulative actuarial survival rates were 95% and 61% at 1 and 3 years, respectively. CONCLUSIONS Because of the high recurrence rates of thromboembolism, it seems necessary to severe anticoagulant therapy. Upper extremity thromboembolism should also be considered as one manifestation of a systemic embolism.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002406 Catheterization, Peripheral Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes. Arterial Catheterization, Peripheral,Catheterization, Bronchial,Catheterization, Peripheral Arterial,Catheterization, Peripheral Venous,Peripheral Catheterization,Venous Catheterization, Peripheral,Bronchial Catheterization,PICC Line Catheterization,PICC Line Placement,PICC Placement,Peripheral Arterial Catheterization,Peripheral Venous Catheterization,Peripherally Inserted Central Catheter Line Insertion,Arterial Catheterizations, Peripheral,Bronchial Catheterizations,Catheterization, PICC Line,Catheterizations, Bronchial,Catheterizations, PICC Line,Catheterizations, Peripheral,Catheterizations, Peripheral Arterial,Catheterizations, Peripheral Venous,PICC Line Catheterizations,PICC Line Placements,PICC Placements,Peripheral Arterial Catheterizations,Peripheral Catheterizations,Peripheral Venous Catheterizations,Placement, PICC,Placement, PICC Line,Placements, PICC,Placements, PICC Line,Venous Catheterizations, Peripheral
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
February 2015, Annals of vascular surgery,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
January 2014, Plastic surgery (Oakville, Ont.),
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
January 1994, European journal of vascular surgery,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
November 2023, Journal of vascular surgery,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
June 2024, Journal of vascular surgery,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
August 1997, Canadian journal of surgery. Journal canadien de chirurgie,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
April 2019, Plastic and reconstructive surgery,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
August 1963, American journal of surgery,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
May 2016, Journal of thrombosis and haemostasis : JTH,
Katsuaki Magishi, and Yuichi Izumi, and Noriyuki Shimizu
July 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
Copied contents to your clipboard!